AHMEDABAD, India (June 13, 2025) - Dishman Carbogen Amcis Ltd’ Naroda manufacturing facility went through an inspection by the USFDA between 9^th to 12^th June, 2025, which was concluded without any observations, confirming that no concerns were identified.

Paolo Armanino, COO of Dishman Carbogen Amcis Ltd, spoke about the company's achievement regarding the recent USFDA inspection: 

"Once again, the successful completion of the USFDA inspection, without observations, of our Naroda manufacturing facility reaffirms our organization’s commitment to consistently maintaining the highest quality standards over time.  

 I want to extend my heartfelt congratulations to all team members for their dedication and hard work. I am also extremely proud of all our subject matter experts across India who supported the pre-inspection activities. 

 The successful inspection at Naroda, along with last year's approvals from PMDA Japan, EDQM/AIFA, and the USFDA for our Bavla site, underscores Dishman Carbogen Amcis Ltd’ track record of delivering high-quality manufacturing services. 

 I would like to take this opportunity to sincerely appreciate the company’s promoters, who have been instrumental and played a crucial role in supporting the quality strategy. Their efforts have ensured that all Dishman group pharma facilities are established and maintained according to the highest international standards.”  

****

Dishman Carbogen Amcis Ltd (www.imdcal.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. Dishman Carbogen Amcis group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe, in China and in India.

CARBOGEN AMCIS (www.carbogen-amcis.com) is a leading service provider offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries across all stages of clinical development and product life cycle. Our integrated services and innovative chemistry solutions support timely and safe drug development, allowing customers to better optimize available resources. CARBOGEN AMCIS is a wholly owned subsidiary of Dishman Carbogen Amcis Ltd, Ahmedabad, India.